Eli Lilly & Co. (LLY)

988.16 +20.23 (+2.09%) USD  |  NYSE  |  May 05, 16:00
986.25 -1.91 (-0.19%) After-Hours: 19:04
More

Eli Lilly Free Cash Flow : 10.37B for March 31, 2026

Free Cash Flow Chart

View Free Cash Flow for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 3.791B
Viking Therapeutics, Inc. -340.33M
Apellis Pharmaceuticals, Inc. 45.01M
Arcellx, Inc. -212.58M
Moderna, Inc. -1.603B

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 5.333B
Cash from Investing (Quarterly) -3.916B
Cash from Financing (Quarterly) -3.47B
Free Cash Flow Per Share (Quarterly) 3.129
Free Cash Flow to Equity (Quarterly) 3.298B
Free Cash Flow to Firm (Quarterly) 3.014B
Free Cash Flow Yield 1.15%